Skip to main content
Psychopharmacology Bulletin All Volumes & Issues VOL 54 No. 2 A Bell’s Palsy...
LETTER TO THE EDITOR

A Bell’s Palsy Case Probably Related to Sertraline Use

Psychopharmacology Bulletin 54(2) :51-52 , 2024/04/04

Abstract

Bell’s palsy is a peripheral facial nerve dysfunction that presents clinically as acute, unilateral partial, or complete paralysis of the face and is primarily idiopathic in origin.1 While the etiology is unclear, anatomical, viral infectious, ischemic, inflammatory, and cold exposure theories for Bell’s palsy have been proposed.2 According to a phase-IV clinical study of FDA data, there are 22 Bell’s palsy cases reported during sertraline use between the years 1998 and 2022.3 In the literature, there are two reported cases of Bell’s palsy related to combination treatment with sertraline and quetiapine.4 Here we present a Bell’s palsy case that developed two months after starting a low dosage of sertraline.

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Mehmet Emin Ceylan, Barış Önen Ünsalver, Hatice Zeynep Ceylan. A Bell’s Palsy Case Probably Related to Sertraline Use. Psychopharmacology Bulletin. 2024/04/04; 54(2):51-52.